Hepatitis C virus inhibitors

A compound of Formula (II), or a pharmaceutically acceptable salt thereof:

• E is absent or a cyclic group independently selected from aryl, heteroaryl, heterocyclic, C3-C8 cycloalkyl, and C3-C8 cycloalkenyl, each optionally substituted;
• T is absent or an optionally substituted aliphatic group:
• Ring G is a 5/6-membered fused heteroaryl other than benzimidazolyl, wherein the 6-membered ring of said 5/6-membered fused heteroaryl is attached to T, and wherein the 5-membered ring of said 5/6-membered fused heteroaryl is attached to group Q and contains one or more nitrogen atoms;
• and wherein said 5/6-membered fused heteroaryl is optionally substituted:
• Wherein Q in Formula II is represented by
• R12 at each occurrence is independently selected from the group consisting of —O— and R11, —NRaRb, —R13, and —NRcRd;
• R11 at each occurrence is independently hydrogen or optionally substituted C1-C8 alkyl;
• and
• Ra and Rb at each occurrence are each independently selected from the group consisting of hydrogen, optionally substituted C1-C8 alkyl, and optionally substituted C2-C8 alkenyl;
• or Ra and Rb can be taken together with the nitrogen atom to which they are attached to form an optionally substituted heterocyclic or optionally substituted heteroaryl group;
• R13 at each occurrence is independently selected from the group consisting of:
• hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8-alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted;
• and
• Rc and Rd at each occurrence are each independently selected from the group consisting of hydrogen, —R13, —C(O)—R13, —C(O)—OR13, —S(O)2—R13, —C(O)N(R13)2, and —S(O)2N(R13)2;
• m is 0, 1, or 2;
• n is 1, 2, 3, or 4;
• X at each occurrence is independently selected from O, S, S(O), SO2, and C(R7)2;
• provided that when m is 0, X is C(R7)2;
• and
• R7 at each occurrence is independently selected from the group consisting of:
• hydrogen, halogen, cyano, —O—R11, —NRaRb, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted —C1-C4 alkyl;
• or two vicinal R7 groups are taken together with the two adjacent atoms to which they are attached to form a fused, optionally substituted C3-C8 cycloalkyl or optionally substituted heterocyclic ring:
• or alternatively two geminal R7 groups are taken together with the carbon atom to which they are attached to form a spiro, optionally substituted C3-C8 cycloalkyl or optionally substituted heterocyclic ring.